Xeris Biopharma Director Dawn Halkuff Executes $121,885 Stock Sale and Receives Equity Grants
Dawn Halkuff, a director at Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), executed a sale of 20,000 shares on June 4, 2026, valued at $121,885. The transaction, conducted under a pre-established Rule 10b5-1 trading plan, was accompanied by the receipt of restricted stock units and stock options. This activity follows the company's reported first-qu…